For Dry Age-related Macular Degeneration (AMD)
The first and only FDA-authorized treatment for dry AMD to improve and maintain vision for up to 2 years. Photobiomodulation (PBM) Light Therapy uses a unique mechanism of action works to restore cellular energy production and improve retinal cellular health.
• More than 60% of PBM-treated patients experienced ≥1-line vision improvement at about 2 years compared to baseline.
• 84% of PBM-treated patients maintained or improved vision at about 2 years compared to baseline.
NO drops, NO speculum, NO injections
The process takes less than 5 minutes per eye.
• Now accepting dry AMD patients with:
• Vision 20/32 to 20/70
• Presence of:
○ 3 medium Drusen or
○ large Drusen or
○ non-central GA
• absence of wet or center-involving GA
Read more about the results of PBM here.
Visit Alcon’s page for more information here.
